Evidence map›Paper›PMID 41467804›Full record

ArticleAntimicrobial agents and chemotherapy2026

Jun Luo, Min Liu, Wen Ai, Xiaoling Zheng, Lu Han, Kuo Huang, Changlin Zhang, Jinhong Fan, Qianyuan Li, Chunhua Luo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jun LuoThe First College of Clinical Medical Science, China Three Gorges University, Yichang, China.ORCID 0000-0001-9691-9086
Min LiuThe First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Wen AiThe First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Xiaoling ZhengThe First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Lu HanThe First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Kuo HuangThe First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Changlin ZhangThe First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Jinhong FanThe First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Qianyuan LiThe First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Chunhua LuoThe First College of Clinical Medical Science, China Three Gorges University, Yichang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The combined use of phages and antibiotics offers an alternative avenue against multidrug-resistant bacteria. We have previously described the synergistic antibacterial effect of the phage pB23 and meropenem combination against carbapenem-resistant

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsBacterial ProteinsBacteriophagesCarbapenemsMeropenemAcinetobacter InfectionsAnimalsBiofilmsDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsMutationPhage TherapyVirulenceZebrafishAnti-Bacterial AgentsBacterial ProteinsCarbapenemsMeropenemcarbapenem resistance attenuationcarbapenem-resistant Acinetobacter baumanniiGtr9phage-antibiotic synergytrade-off mechanism

Identifiers

PMID41467804
PMCPMC12888894

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.